HELX
Franklin Genomic Advancements ETF
Franklin Templeton ETF Trust
ETF

Portfolio moves

Net position changes between two of this fund's N-PORT snapshots. These are differences between point-in-time reports — not a trade log — and share counts can be affected by splits and other corporate actions.

Dec 31, 2025 → Mar 31, 2026

Expand a category to see the positions behind it, ranked by weight.

Security Shares Dec 2025 Shares Mar 2026 Δ shares End % Δ value
ASTRAZENECA PLC 0 3,695 3,695 3.50% $728.73K
QIAGEN NV 0 3,175 3,175 0.61% $127.13K
ANAPTYSBIO INC 0 2,041 2,041 0.54% $113.19K
TARSUS PHARMACEUTICALS INC 0 1,487 1,487 0.50% $104.31K
Security Shares Dec 2025 Shares Mar 2026 Δ shares End % Δ value
ASTRAZENECA PLC SPONS ADR 6,626 0 -6,626 0.00% -$609.13K
EXACT SCIENCES CORP 4,864 0 -4,864 0.00% -$493.99K
QIAGEN NV 3,086 0 -3,086 0.00% -$138.78K
DOXIMITY INC-A 2,692 0 -2,692 0.00% -$119.20K
DYNAVAX TECHNOLOGIES CORP 2,030 0 -2,030 0.00% -$31.22K
SCHRODINGER INC 1,254 0 -1,254 0.00% -$22.42K
Security Shares Dec 2025 Shares Mar 2026 Δ shares End % Δ value
GUARDANT HEALTH INC 14,509 15,718 1,209 6.98% -$30.08K
NATERA INC 6,583 7,131 548 6.86% -$81.97K
KRYSTAL BIOTECH INC 4,079 4,418 339 5.49% $135.62K
UNITED THERAPEUTICS CORP DEL 1,551 1,680 129 4.79% $240.48K
INSMED INC 5,476 5,932 456 4.66% $16.96K
BRIDGEBIO PHARMA INC 11,255 12,192 937 4.35% $44.48K
LIGAND PHARMACEUTICALS 3,503 3,794 291 3.64% $95.16K
ADAPTIVE BIOTECHNOLOGIES CORP 44,534 48,245 3,711 3.22% -$53.59K
VERTEX PHARMACEUTICALS INC 1,325 1,435 110 3.08% $40.08K
SAMSUNG BIOLOGIC 602 652 50 3.08% -$68.10K
REGENERON PHARMACEUTICALS INC 667 748 81 2.78% $63.10K
CORTEVA INC 6,373 6,904 531 2.78% $150.75K
LILLY ELI and CO 548 593 45 2.62% -$43.50K
IONIS PHARMACEUTICALS INC 5,499 5,957 458 2.15% $12.29K
TEMPUS AI INC-A 8,512 8,726 214 1.90% -$108.04K
BIONTECH SE ADR 4,007 4,340 333 1.85% $4.27K
NEUROCRINE BIOSCIENCES INC 2,486 2,693 207 1.71% $2.19K
STOKE THERAPEUTICS INC 5,718 10,539 4,821 1.65% $161.66K
TWIST BIOSCIENCE CORP 6,020 7,184 1,164 1.64% $150.43K
ARGENX SE 424 459 35 1.58% -$28.63K
PTC THERAPEUTICS INC 4,295 4,652 357 1.52% -$9.31K
TRAVERE THERAPEUTICS INC 9,350 10,129 779 1.45% -$56.33K
CHARLES RIVER LABS INTL INC 1,334 1,445 111 1.20% -$16.84K
CRISPR THERAPEUTICS AG 2,924 4,671 1,747 1.07% $68.86K
REPLIGEN CORP 1,723 1,866 143 1.06% -$62.48K
VERACYTE INC 6,266 6,788 522 1.05% -$45.16K
PRAXIS PRECISION MEDICINES INC 289 667 378 1.03% $129.72K
GRAIL INC 3,820 4,138 318 1.03% -$113.10K
Sartorius Aktiengesellschaft 777 841 64 0.99% -$20.25K
DANAHER CORP 970 1,050 80 0.96% -$22.97K
THERMO FISHER SCIENTIFIC INC 361 391 30 0.92% -$16.99K
IQVIA HOLDINGS INC 928 1,005 77 0.82% -$37.79K
BEAM THERAPEUTICS INC 6,495 7,036 541 0.81% -$12.37K
JAZZ PHARMA PLC 777 841 64 0.76% $26.90K
CATALYST PHARMACEUTICALS INC 5,117 6,375 1,258 0.76% $38.41K
CADENCE DESIGN SYSTEMS INC 504 545 41 0.73% -$6.10K
AGILENT TECHNOLOGIES INC 1,049 1,136 87 0.62% -$13.26K
CAREDX INC 6,858 7,429 571 0.62% -$237
SAMSUNG EPISHOLD 324 350 26 0.54% -$54.23K
ARCUTIS BIOTHERAPEUTICS INC 3,792 4,107 315 0.47% -$13.36K
AXSOME THERAPEUTICS INC 523 566 43 0.46% $145
RHYTHM PHARMACEUTICALS INC 900 974 74 0.41% -$11.63K
HINGE HEALTH INC 2,015 2,182 167 0.40% -$9.46K
BRISTOL-MYERS SQUIBB CO 702 1,111 409 0.32% $29.52K
BIO RAD LABS CL A 209 226 17 0.30% -$327
BEONE MEDICINES LTD ADR 193 209 16 0.30% $3.43K
TRANSMEDICS GROUP INC 445 482 37 0.23% -$6.22K
NEUROGENE INC 1,699 1,840 141 0.18% $2.10K
WAVE LIFE SCIENCES LTD 4,127 4,470 343 0.16% -$37.75K
Security Shares Dec 2025 Shares Mar 2026 Δ shares End % Δ value
MEDPACE HOLDINGS INC 1,708 1,327 -381 3.06% -$322.09K
ALNYLAM PHARMACEUTICALS INC 1,982 1,687 -295 2.68% -$229.96K
ULTRAGENYX PHARMA INC 5,409 4,765 -644 0.48% -$24.58K
GENEDX HOLDINGS CORP-A 3,816 1,409 -2,407 0.44% -$405.82K
RECURSION PHARMACEUTICALS INC 16,145 10,393 -5,752 0.15% -$34.13K
CARIS LIFE SCIENCES INC 1,892 557 -1,335 0.05% -$41.09K
Security Shares Dec 2025 Shares Mar 2026 Δ shares End % Δ value
OMNIAB INC - 12.5 EARNOUT 240 240 0 0.00% $0
OMNIAB INC - 15.00 EARNOUT 240 240 0 0.00% $0

Machine-readable: JSON · Markdown. Programmatic access via the agent surface.